VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $84,674,000 | +173.4% | 3,597,551 | +84.9% | 0.08% | +157.6% |
| Q1 2018 | $30,967,000 | +72.0% | 1,945,458 | +126.0% | 0.03% | +73.7% |
| Q4 2017 | $17,999,000 | +316.4% | 860,775 | +184.6% | 0.02% | +280.0% |
| Q3 2017 | $4,323,000 | -18.2% | 302,414 | -0.7% | 0.01% | -28.6% |
| Q2 2017 | $5,286,000 | +51.5% | 304,571 | -3.9% | 0.01% | +40.0% |
| Q1 2017 | $3,490,000 | -32.2% | 316,880 | -10.7% | 0.01% | -28.6% |
| Q4 2016 | $5,149,000 | -49.6% | 354,661 | -15.0% | 0.01% | -56.2% |
| Q3 2016 | $10,218,000 | +22.7% | 417,166 | +0.5% | 0.02% | +6.7% |
| Q2 2016 | $8,328,000 | -7.7% | 415,176 | +21.1% | 0.02% | -6.2% |
| Q1 2016 | $9,023,000 | -72.1% | 342,770 | +7.2% | 0.02% | -71.9% |
| Q4 2015 | $32,367,000 | -45.8% | 319,874 | -4.9% | 0.06% | -52.1% |
| Q3 2015 | $59,767,000 | -12.0% | 336,365 | +9.9% | 0.12% | -11.9% |
| Q2 2015 | $67,901,000 | +21.9% | 305,953 | +8.5% | 0.14% | +6.3% |
| Q1 2015 | $55,725,000 | +42.3% | 282,066 | +3.5% | 0.13% | +54.9% |
| Q4 2014 | $39,149,000 | +747.0% | 272,616 | +673.8% | 0.08% | +530.8% |
| Q3 2014 | $4,622,000 | +3.7% | 35,229 | -0.3% | 0.01% | +8.3% |
| Q2 2014 | $4,456,000 | -7.2% | 35,329 | -3.0% | 0.01% | -14.3% |
| Q1 2014 | $4,802,000 | +15.8% | 36,429 | +3.1% | 0.01% | +16.7% |
| Q4 2013 | $4,148,000 | -41.2% | 35,329 | -47.8% | 0.01% | -52.0% |
| Q3 2013 | $7,059,000 | -72.3% | 67,659 | -77.2% | 0.02% | -72.2% |
| Q2 2013 | $25,497,000 | +1090.9% | 296,206 | +726.7% | 0.09% | +900.0% |
| Q4 2012 | $2,141,000 | – | 35,829 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |